ABBV · NYQ S&P 500

AbbVie Inc.

Healthcare · Drug Manufacturers - General

$293.89 +$0.59 (+0.20%) today

Closing price on Nov 10, 2026 · Source: Yahoo Finance

Consensus of 29 analysts

Buy

Median price target $317.00 +7.9%

Open: $292.50
Day range: 291.04 – $294.50
52-week range: 190.75 – $302.93
Volume: 3,471,430
Market cap: $519,485M
P/E (TTM): 50.5x
EPS (TTM): $5.82
EPS est. 2026: $13.98
P/E est. 2026: 21.0x
Dividend yield: 2.4%
Beta: 0.19
Payout: 117%

AbbVie financials

Q3 2026 results, quarter ended Sep 30, 2026

Metric	Q3 2026	1-year change
Total revenue	$17,404M	+10.3%
Net income	$4,218M	+2,167.7%
Earnings per share	$2.37	+2,270.0%
Net margin	24.2%	+23.1 pp
Free cash flow	$7,305M	+10.0%
Debt / equity	−17.65	n/s

Revenue and net income ($M)

Total revenueNet income

Quarter	Total revenue	Net income
Q3 2025	$15,776M	$186M
Q4 2025	$16,618M	$1,816M
Q1 2026	$15,002M	$695M
Q2 2026	$16,990M	$3,613M
Q3 2026	$17,404M	$4,218M

AbbVie earnings per share (EPS)

Consensus estimates

Period	EPS est.	1-year change
Current quarterQ4 2026 · Analysts: 20	$3.8783.81 – 4.01	+43.1%$2.710
Next quarterQ1 2027 · Analysts: 9	$3.4373.31 – 3.90	+29.7%$2.650
Current year2026 · Analysts: 27	$13.98313.93 – 14.13	+39.8%$10.000
Next year2027 · Analysts: 29	$16.19815.31 – 17.23	+15.8%$13.983

Forward P/E: 21.0x (2026) and 18.1x (2027) at the current price.

Actual and estimated EPS ($)

Actual EPSEstimated EPS

Quarter	Actual EPS	Estimated EPS
Q3 2025	$0.100	—
Q4 2025	$2.710	$2.653
Q1 2026	$2.650	$2.671
Q2 2026	$3.650	$3.608
Q3 2026	$3.820	$3.765
Q4 2026	—	$3.878
Q1 2027	—	$3.437

Year	Actual EPS	Estimated EPS
2022	$6.630	—
2023	$2.720	—
2024	$2.390	—
2025	$2.370	—
2026	—	$13.983
2027	—	$16.198

EPS trend

Quarter	EPS	YoY change
Q1 2027Estimated	$3.437	+29.7%
Q4 2026Estimated	$3.878	+43.1%
Q3 2026	$3.820est. $3.765 · surprise +1.5%	+3,720.0%
Q2 2026	$3.650est. $3.608 · surprise +1.2%	n/a
Q1 2026	$2.650est. $2.671 · surprise −0.8%	n/a
Q4 2025	$2.710est. $2.653 · surprise +2.2%	n/a
Q3 2025	$0.100	n/a

Year	EPS	Annual change
2027Estimated	$16.198	+15.8%
2026Estimated	$13.983	+490.0%
2025	$2.370	−0.8%
2024	$2.390	−12.1%
2023	$2.720	−59.0%
2022	$6.630	n/a

Normalised EPS according to the analyst consensus collected by Yahoo Finance; it may differ from the reported EPS in the results table.

AbbVie dividend

Yield and payments

Dividend yield (TTM)	2.4%
Forward yield (next 12m)	2.4%
Dividend per share (TTM)	$6.92
Forward dividend (next 12m)	$6.92
Payout (TTM)	117%
Last dividend	$1.73Oct 15, 2026
Next ex-dividend date	Jan 15, 2027

Dividend per share by year ($)

PaidEstimated

Year	Dividend per share
2019	$4.28
2020	$4.72
2021	$5.20
2022	$5.64
2023	$5.92
2024	$6.20
2025	$6.56
est. 12m	$6.92

AbbVie forecasts

29 analyst ratings

Buy79% Hold17% Sell3%

Consensus: Buy · 23 buy, 5 hold, 1 sell

1-year price forecast

Share price Price target (high, median, low)

12-month price targets
Target	Price	Upside
High	$350.00	+19.1%
Median	$317.00	+7.9%
Low	$237.00	−19.4%

Monthly close (last 12 months)
Date	Close
Nov 28, 2025	$227.70
Dec 31, 2025	$228.49
Jan 30, 2026	$223.01
Feb 27, 2026	$232.08
Mar 31, 2026	$217.49
Apr 30, 2026	$211.32
May 29, 2026	$217.72
Jun 30, 2026	$251.64
Jul 31, 2026	$250.94
Aug 31, 2026	$256.42
Sep 30, 2026	$261.59
Oct 30, 2026	$294.89
Nov 10, 2026	$293.89

AbbVie peers

Ticker	Company	Market cap ($M)	P/E	Price ($)	1-day change	52-week range
ABBV	AbbVie	519,485	50.5x	293.89	+0.20%	190.75302.93
LLY	Lilly	1,275,805	46.5x	1,432.29	+1.44%	850.511,453.00
JNJ	Johnson & Johnson	675,925	42.6x	280.78	−0.47%	189.05283.25
MRK	Merck &	364,980	149.5x	148.05	−0.48%	87.26156.92
AMGN	Amgen	251,648	27.0x	465.23	0.00%	312.39483.99
GILD	Gilead Sciences	211,937	n/a	170.87	+0.92%	116.88176.58